NMR structure of the first Ig module of mouse FGFR1

Protein Science

Volumn 15, Issue 6, 2006, Pages 1512-1515

  Kiselyov, Vladislav V ^a   Bock, Elisabeth ^a   Berezin, Vladimir ^a   Poulsen, Flemming M ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

Author keywords

FGFR Ig module 1 structure; NMR

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3;

ARTICLE; BETA SHEET; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; IMMUNOGLOBULIN STRUCTURE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN FOLDING; STRUCTURE ANALYSIS;

ANIMALS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SOLUTIONS;

EID: 33744456248     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.062207906     Document Type: Article

References (23)

1. Bottcher, R.T. and Niehrs, C. 2005. Fibroblast growth factor signaling during early vertebrate development. Endocr. Rev. 26: 63-77.
2. Brünger, A.T. 1992. X-PLOR software manual, version 3.1. Yale University, New Haven, CT.
3. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6: 277-293.
4. Doherty, P. and Walsh, F.S. 1996. CAM-FGF receptor interactions: A model for axonal growth. Mol. Cell. Neurosci. 8: 99-111.
5. Itoh, N. and Ornitz, D.M. 2004. Evolution of the Fgf and Fgfr gene families. Trends Genet. 20: 563-569.
6. Kiselyov, V.V., Skladchikova, G., Hinsby, A.M., Jensen, P.H., Kulahin, N., Soroka, V., Pedersen, N., Tsetlin, V., Poulsen, F.M., Berezin, V., et al. 2003. Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure 11: 691-701.
7. 15N resonance assignment of the first module of FGFR1. J. Biomol. NMR (in press).
8. Kjaer, M., Andersen, K.V., and Poulsen, F.M. 1994. Automated and semi-automated analysis of homo- and heteronuclear multidimensional nuclear magnetic resonance spectra of proteins: The program Pronto. Methods Enzymol. 239: 288-307.
9. Koradi, R., Billeter, M., and Wuthrich, K. 1996. MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 29-32, 51-55.
10. Laskowski, R.A., Moss, D.S., and Thornton, J.M. 1993. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231: 1049-1067.
11. McKeehan, W.L., Wang, F., and Kan, M. 1998. The heparan sulfate-fibroblast growth factor family: Diversity of structure and function. Prog. Nucleic Acid Res. Mol. Biol. 59: 135-176.
12. Miki, T., Bottaro, D.P., Fleming, T.P., Smith, C.L., Burgess, W.H., Chan, A.M., and Aaronson, S.A. 1992. Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. 89: 246-250.
13. Olsen, S.K., Ibrahimi, O.A., Raucci, A., Zhang, F., Eliseenkova, A.V., Yayon, A., Basilico, C., Linhardt, R.J., Schlessinger, J., and Mohammadi, M. 2004. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc. Natl. Acad. Sci. 101: 935-940.
14. Ornitz, D.M., Yayon, A., Flanagan, J.G., Svahn, C.M., Levi, E., and Leder, P. 1992. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12: 240-247.
15. Pellegrini, L., Burke, D.F., von Delft, F., Mulloy, B., and Blundell, T.L. 2000. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407: 1029-1034.
16. Plotnikov, A.N., Schlessinger, J., Hubbard, S.R., and Mohammadi, M. 1999. Structural basis for FGF receptor dimerization and activation. Cell 98: 641-650.
17. Plotnikov, A.N., Hubbard, S.R., Schlessinger, J., and Mohammadi, M. 2000. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101: 413-424.
18. Schlessinger, J., Plotnikov, A.N., Ibrahimi, O.A., Eliseenkova, A.V., Yeh, B.K., Yayon, A., Linhardt, R.J., and Mohammadi, M. 2000. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6: 743-750.
19. Shimizu, A., Tada, K., Shukunami, C., Hiraki, Y., Kurokawa, T., Magane, N., and Kurokawa-Seo, M. 2001. A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells. J. Biol. Chem. 276: 11031-11040.
20. Wang, F., Kan, M., Xu, J., Yan, G., and McKeehan, W.L. 1995a. Ligand-specific structural domains in the fibroblast growth factor receptor. J. Biol. Chem. 270: 10222-10230.
21. 2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1. J. Biol. Chem. 270: 10231-10235.
22. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., and Ornitz, D.M. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.
23. Yayon, A., Zimmer, Y., Shen, G.H., Avivi, A., Yarden, Y., and Givol, D. 1992. A confined variable region confers ligand specificity on fibroblast growth factor receptors: Implications for the origin of the immunoglobulin fold. EMBO J. 11: 1885-1890.